KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Cash & Current Investments (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Cash & Current Investments for 9 consecutive years, with $13.3 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 39.91% to $13.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.3 million through Dec 2025, up 39.91% year-over-year, with the annual reading at $13.3 million for FY2025, 39.91% up from the prior year.
  • Cash & Current Investments hit $13.3 million in Q4 2025 for Bionano Genomics, down from $21.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $362.1 million in Q1 2021 to a low of $5.1 million in Q4 2022.
  • Historically, Cash & Current Investments has averaged $115.7 million across 5 years, with a median of $65.2 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: surged 4369.84% in 2021 and later plummeted 97.97% in 2022.
  • Year by year, Cash & Current Investments stood at $250.6 million in 2021, then crashed by 97.97% to $5.1 million in 2022, then surged by 1211.55% to $66.8 million in 2023, then crashed by 85.81% to $9.5 million in 2024, then skyrocketed by 39.91% to $13.3 million in 2025.
  • Business Quant data shows Cash & Current Investments for BNGO at $13.3 million in Q4 2025, $21.6 million in Q3 2025, and $16.5 million in Q2 2025.